首页>
外国专利>
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER COMPRISING ALLOGENIC LYMPHOCYTES OR THEIR COMBINATION WITH A T-CELL ACTIVATOR
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER COMPRISING ALLOGENIC LYMPHOCYTES OR THEIR COMBINATION WITH A T-CELL ACTIVATOR
展开▼
机译:用于治疗同种异体淋巴细胞癌或与T细胞活化剂联合使用的药物组合物
展开▼
页面导航
摘要
著录项
相似文献
摘要
Methods have been discovered for treating minimal residual disease following removal of most or a substantial fraction of malignant cells from a cancer patient. An autologous stem cell transplant is performed on the patient. Following partial hematopoiesis recovery, the patient is infused with allogeneic peripheral blood lymphocytes, either alone or in combination with in vivo or in vitro cytokine. The infused allogeneic lymphocytes engender an anti-malignant cell response and can be instrumental in prevention of disease relapse.
展开▼